Related Experiment Videos
Frequent K-ras mutations in small bowel adenocarcinomas
1Columbia-Presbyterian Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
Digestive Diseases and Sciences
|January 1, 1996
Summary
Small bowel adenocarcinomas are rare, but K-ras mutations were found in most examined cases. This suggests the small intestine may have protective mechanisms against cancer formation despite carcinogen exposure.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Small bowel adenocarcinomas are significantly less common than colonic adenocarcinomas.
- The underlying reasons for this disparity in incidence remain largely unknown.
- Activating K-ras oncogene mutations are frequent in colonic adenocarcinomas, potentially linked to carcinogen exposure.
Purpose of the Study:
- To investigate the frequency of K-ras mutations in small bowel adenocarcinomas.
- To determine if the lower incidence of small bowel cancer is due to a lack of oncogene activation.
- To explore potential protective mechanisms in the small intestine against cancer development.
Main Methods:
- Analysis of K-ras mutations at codon 12 in small bowel adenocarcinoma samples.
- Utilized polymerase chain reaction (PCR) for amplification.
- Employed restriction fragment length polymorphism to detect point mutations.
Main Results:
- PCR amplification was successful in 6 out of 9 small bowel adenocarcinoma samples.
- K-ras point mutations at codon 12 were identified in 5 of these 6 cases.
- A high frequency of K-ras mutations was observed in the analyzed small bowel adenocarcinomas.
Conclusions:
- The small intestine may be exposed to similar carcinogens as the colon.
- The presence of K-ras mutations suggests oncogene activation occurs in small bowel adenocarcinomas.
- The small bowel might possess inherent protective mechanisms that prevent widespread cancer formation.